Low BMI Is a Predictor of Death for TAVI

Courtesy of Dr. Carlos Fava.

 

low BMI death TAVI

 

Body mass index (BMI) has always played an important role in heart surgery. However, there is little evidence on BMI effects on TAVI.

This study included 491 patients, which were divided according to BMI into:

 

  • low (<20 Kg/m2 )
  • normal (20-24.9 Kg/m2 )
  • overweight (25-30 Kg/m2 )
  • obese (>30 Kg/m2 )

 

BMI was low in 43 patients (8.7%), normal in 148 (30.1%), overweight in 162 (33%) and obese in 138 (28.1%).

Obese patients were younger, diabetes was more frequent among morbid obese, but there were fewer with prior MI.

STS score was inversely associated with BMI:

Low weight: 11.4±4.9

Normal: 9.1±4.8

Overweight: 8.4±4.3

Obesity: 7.9±4

[p<0.001]

Ejection fraction was also inversely associated to BMI, but the opposite happened with the aortic valve area.

There was no difference in procedural success, except for longer fluoroscopy time in the group with morbid obesity. Vascular complications and transfusions (VARC-2 criteria) were higher in the low BMI group, while acute kidney injury was higher in the highest BMI group.

At one year follow up, all-cause mortality was higher in the low BMI group compared to the other 3 groups (p=0.003).

In multivariable analyzis, BMI <20 Kg/mwas an independent predictor of mortality (HR=2.45; p=0.01).

 

Conclusion

Body mass index <20 Kg/mshould be considered a fragility marker during screening for TAVI of patients with severe aortic stenosis, since it is associated to high mortality, while obese patients presented similar mortality risk to those of normal weight.

 

Editorial Comment

BMI should be included as part of patient screening routine procedures when considering TAVI, because it is associated with in-hospital complications and mortality. BMI could be used as a sign of fragility. We should controlling fluid balance in morbid obesity because these patients present higher kidney failure rate after implantation, which can be associated to loss of volume, hard to recover immediately after procedure.

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

Original Title: Body Mass Index Association with Survival in Severe Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Replacement

Reference: Edward Koifman, et al. Cateheterization cardiovascular Intervention 2016;88:118-124

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...